PsiQuantum has announced a surprise leadership restructure, switching co-founder and chief executive Jeremy O’Brien to an executive chair role as the quantum developer pursues a pivot from research to...
The Morrison government went against departmental advice to continue negotiating with another tenderer for a local mRNA vaccine capability and instead handed Moderna a deal that will pay the...
An audit that the Heath department attempted to obstruct and censor shows it went against legal advice and market intelligence to recommend the Morrison government single source $1 billion...
An audit of the federal government’s controversial deal to bring Moderna to Melbourne to manufacture vaccines has been quietly delayed by four months, pushing its findings into the summer...
Australian biotechnology giant CSL has announced plans for a $2.3 billion expansion of its manufacturing operations in the United States as it seeks to skirt US President Donald Trump’s...
Atlassian, CSL and Cochlear are the biggest users of Australia’s research and development tax incentive, with the software giant alone claiming more than $200 million of activity a year,...
A $28.5 million commercialisation boost will soon be available to MedTechs fighting heart disease and diabetes under the latest round of a Medical Research Future Fund program. The second...
A wearable “lab-on-a-chip” solution for hormone monitoring, a gum disease vaccine and technology for creating 3D models of human brain tissue are among the ideas that have piqued the...
The federal government is considering further support for parts of the RNA sector after helping establish the southern hemisphere’s first commercial mRNA manufacturing capability in Melbourne. The Industry department...
A new biotech incubator backed by $65 million in industry and government investment has launched, offering innovative Australian startups access to a wet lab space and other facilities in...